Number of the records: 1  

Polyphasic data support the splitting of Aspergillus candidus into two species, proposal of Aspergillus dobrogensis sp nov.

  1. 1.
    SYSNO ASEP0494189
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitlePolyphasic data support the splitting of Aspergillus candidus into two species, proposal of Aspergillus dobrogensis sp nov.
    Author(s) Hubka, Vít (MBU-M) ORCID
    Nováková, Alena (MBU-M) ORCID
    Jurjević, Ž. (US)
    Sklenář, František (MBU-M) ORCID
    Frisvad, J.C. (DK)
    Houbraken, J. (NL)
    Arendrup, M.C. (DK)
    Jorgensen, K.M. (DK)
    Sigueira, J.P.Z. (ES)
    Gené, J. (ES)
    Kolařík, Miroslav (MBU-M) RID, ORCID
    Source TitleInternational Journal of Systematic and Evolutionary Microbiology. - : Microbiology Society - ISSN 1466-5026
    Roč. 68, č. 4 (2018), s. 995-1011
    Number of pages17 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsantifungal susceptibility testing ; antioxidant compounds ; bioprospecting
    Subject RIVEE - Microbiology, Virology
    OECD categoryMicrobiology
    R&D ProjectsGA17-20286S GA ČR - Czech Science Foundation (CSF)
    ED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportMBU-M - RVO:61388971
    UT WOS000433170100004
    EID SCOPUS85044924162
    DOI10.1099/ijsem.0.002583
    AnnotationAspergillus candidus is a species frequently isolated from stored grain, food, indoor environments, soil and occasionally also from clinical material. Recent bioprospecting studies highlighted the potential of using A. candidus and its relatives in various industrial sectors as a result of their significant production of enzymes and bioactive compounds. A high genetic variability was observed among A. candidus isolates originating from various European countries and the USA, that were mostly isolated from indoor environments, caves and clinical material. The A. candidus sensu lato isolates were characterized by DNA sequencing of four genetic loci, and agreement between molecular species delimitation results, morphological characters and exometabolite spectra were studied. Classical phylogenetic methods (maximum likelihood, Bayesian inference) and species delimitation methods based on the multispecies coalescent model supported recognition of up to three species in A. candidus sensu lato. After evaluation of phenotypic data, a broader species concept was adopted, and only one new species, Aspergillus dobrogensis, was proposed. This species is represented by 22 strains originating from seven countries (ex-type strain CCF 4651(T) = NRRL 62821(T) = IBT 32697(T) = CBS 143370(T)) and its differentiation from A. candidus is relevant for bioprospecting studies because these species have different exometabolite profiles. Evaluation of the antifungal susceptibility of section Candidi members to six antifungals using the reference EUCAST method showed that all species have low minimum inhibitory concentrations for all tested antifungals. These results suggest applicability of a wide spectrum of antifungal agents for treatment of infections caused by species from section Candidi.
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2019
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.